{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:47:55Z","timestamp":1792705675975,"version":"4.5.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,3]],"date-time":"2014-02-03T00:00:00Z","timestamp":1391385600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0087340","type":"journal-article","created":{"date-parts":[[2014,2,3]],"date-time":"2014-02-03T16:55:56Z","timestamp":1391446556000},"page":"e87340","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":94,"title":["The Candidate TB Vaccine, MVA85A, Induces Highly Durable Th1 Responses"],"prefix":"10.1371","volume":"9","author":[{"given":"Michele","family":"Tameris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hennie","family":"Geldenhuys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelique KanyKany","family":"Luabeya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane E.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Vermaak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem A.","family":"Hanekom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hatherill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Mahomed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"McShane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Scriba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,2,3]]},"reference":[{"key":"ref1","unstructured":"World Health Organisation (2013) Global Tuberculosis Report 2013."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1098\/rsif.2007.1138","article-title":"Eliminating human tuberculosis in the twenty-first century","volume":"5","author":"C Dye","year":"2008","journal-title":"J R Soc Interface"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"13980","DOI":"10.1073\/pnas.0901720106","article-title":"Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics","volume":"106","author":"LJ Abu-Raddad","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1164\/rccm.201003-0334OC","article-title":"Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns","volume":"182","author":"BM Kagina","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nri2960","article-title":"Immunological biomarkers of tuberculosis","volume":"11","author":"G Walzl","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrmicro1419","article-title":"Advances in tuberculosis vaccine strategies","volume":"4","author":"YA Skeiky","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"GA Colditz","year":"1995","journal-title":"Pediatrics"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tube.2010.06.002","article-title":"The Achilles heel of BCG","volume":"90","author":"IM Orme","year":"2010","journal-title":"Tuberculosis (Edinb)"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/eji.200636885","article-title":"Functional and phenotypic characterization of tetanus toxoid-specific human CD4+ T cells following re-immunization","volume":"37","author":"C Cellerai","year":"2007","journal-title":"Eur J Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.4049\/jimmunol.0803903","article-title":"The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response","volume":"183","author":"RS Akondy","year":"2009","journal-title":"J Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10875-008-9267-3","article-title":"Human immune memory to yellow fever and smallpox vaccination","volume":"29","author":"J Wrammert","year":"2009","journal-title":"J Clin Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1128\/IAI.00287-09","article-title":"Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis","volume":"77","author":"HM Vordermeier","year":"2009","journal-title":"Infect Immun"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e5264","DOI":"10.1371\/journal.pone.0005264","article-title":"MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques","volume":"4","author":"FA Verreck","year":"2009","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"NP Goonetilleke","year":"2003","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1128\/IAI.73.6.3814-3816.2005","article-title":"Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs","volume":"73","author":"A Williams","year":"2005","journal-title":"Infect Immun"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e2921","DOI":"10.1371\/journal.pone.0002921","article-title":"Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa","volume":"3","author":"RH Brookes","year":"2008","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1086\/590185","article-title":"Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa","volume":"198","author":"T Hawkridge","year":"2008","journal-title":"J Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"H McShane","year":"2004","journal-title":"Nat Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e000223","DOI":"10.1136\/bmjopen-2011-000223","article-title":"A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults","volume":"1","author":"AM Minassian","year":"2011","journal-title":"BMJ Open"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1016\/j.vaccine.2012.06.054","article-title":"A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants","volume":"30","author":"AA Odutola","year":"2012","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1164\/rccm.200809-1486OC","article-title":"Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals","volume":"179","author":"CR Sander","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/eji.200939754","article-title":"Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells","volume":"40","author":"TJ Scriba","year":"2010","journal-title":"Eur J Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/infdis\/jir195","article-title":"Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants","volume":"203","author":"TJ Scriba","year":"2011","journal-title":"J Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1164\/rccm.201108-1548OC","article-title":"A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV\u2212 and\/or Mycobacterium tuberculosis-infected adults","volume":"185","author":"TJ Scriba","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e5934","DOI":"10.1371\/journal.pone.0005934","article-title":"Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A","volume":"4","author":"KT Whelan","year":"2009","journal-title":"PLoS One"},{"key":"ref26","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","author":"MD Tameris","year":"2013","journal-title":"Lancet"},{"key":"ref27","first-page":"1266","article-title":"The tuberculin skin test: a comparison of ruler and calliper readings","volume":"14","author":"H Geldenhuys","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"F Sallusto","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/QAD.0b013e32832d3b6d","article-title":"Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa","volume":"23","author":"SD Lawn","year":"2009","journal-title":"AIDS"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","article-title":"Cutting edge: long-term B cell memory in humans after smallpox vaccination","volume":"171","author":"S Crotty","year":"2003","journal-title":"J Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.4049\/jimmunol.0801592","article-title":"Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells","volume":"182","author":"T Lindenstrom","year":"2009","journal-title":"J Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1016\/j.vaccine.2010.02.094","article-title":"Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naive human volunteers","volume":"28","author":"JT van Dissel","year":"2010","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0140-6736(13)60137-3","article-title":"A major event for new tuberculosis vaccines","volume":"381","author":"C Dye","year":"2013","journal-title":"Lancet"},{"key":"ref34","unstructured":"World Health Organisation (2013) Consolidated guidelines on the use of retroviral drugs for treating and preventing HIV infection,. 272."},{"key":"ref35","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature10003","article-title":"Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine","volume":"473","author":"SG Hansen","year":"2011","journal-title":"Nature"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"12434","DOI":"10.1073\/pnas.0703510104","article-title":"Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis","volume":"104","author":"HW Mittrucker","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e21566","DOI":"10.1371\/journal.pone.0021566","article-title":"Systemic BCG immunization induces persistent lung mucosal multifunctional CD4 T(EM) cells which expand following virulent mycobacterial challenge","volume":"6","author":"DA Kaveh","year":"2011","journal-title":"PLoS One"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0087340","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T01:42:21Z","timestamp":1648172541000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0087340"}},"subtitle":[],"editor":[{"given":"Anil Kumar","family":"Tyagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,3]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0087340","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,3]]}}}